Tìm kiếm thời gian thực
TopFind đang tìm các kết quả mới nhất cho tìm kiếm của bạn.
Chúng tôi đã xem 12 kết quả trực tiếp cho skyrizi risankizumab rzaa và thu hẹp còn 3 lựa chọn đáng so sánh trước nhất.
Các chủ đề nổi bật nhất trong danh sách này là Immunology và Biologics.
Nguồn: AbbVie Pharmaceuticals (Thailand) Ltd.
Mô tả
Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading.
Phù hợp nhất cho
Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment và Long Term biologic therapy
Đánh giá
Nguồn: AbbVie Inc.
Mô tả
Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body.
Phù hợp nhất cho
Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment và Biologic therapy seekers
Đánh giá
Nguồn: AbbVie Singapore
Mô tả
Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia.
Phù hợp nhất cho
Regional medical reference, Singapore Based patients và Biologic therapy information
Đánh giá
| So sánh | Skyrizi (risankizumab) | Skyrizi (risankizumab-rzaa) | Skyrizi (risankizumab) 150mg |
|---|---|---|---|
| Nguồn | AbbVie Pharmaceuticals (Thailand) Ltd. | AbbVie Inc. | AbbVie Singapore |
| Mô tả | Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading. | Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body. | Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia. |
| Phù hợp nhất cho | Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment và Long Term biologic therapy | Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment và Biologic therapy seekers | Regional medical reference, Singapore Based patients và Biologic therapy information |
| Hành động | |||
| Đánh giá |
Nếu bạn muốn bắt đầu với lựa chọn cân bằng nhất, tôi đề xuất:
"Skyrizi (risankizumab) từ AbbVie Pharmaceuticals (Thailand) Ltd.."
Tôi chọn mục này vì This is the official medication provided by the authorized manufacturer representative in Thailand, ensuring authentic pharmaceutical supply and regulatory oversight.